Besides, our previous report has demonstrated that intra-myocardial injection of AAV-FGF23 in mice significantly worsened diastolic dysfunction and promoted myocardial fibrosis [28], which may contribute to renal damage in CRS. This evidence concerns the gene FGF23 and congenital rubella syndrome.